Alana Lelo

Alana Lelo, PhD, is a Vice President at Guggenheim Partners, where responsibilities include working within the global biopharma sector since June 2021. Previously, Alana held the position of Equity Research Associate, focusing on mega-cap pharmaceutical companies and SMID cap biotech. Prior to Guggenheim Partners, Alana served as a Research Investigator in Discovery Biology at Black Diamond Therapeutics from December 2019 to June 2021. Alana completed a Doctor of Philosophy in Tumor Biology at Georgetown University School of Medicine from 2012 to 2019 and holds a Bachelor of Arts in Chemistry from New York University, obtained between 2006 and 2009.